<p class="xelementtoproof" style="background: white;"> Thomas J. Bollyky (Council on Foreign Relations) joins to explain the problems facing the US pharmaceutical market, the Trump administration's new tariffs and pricing deal with the United Kingdom, and the impact on American drug prices as well as supply chain security (30:10).</p>

Thomas J. Bollyky (Council on Foreign Relations) joins to explain the problems facing the US pharmaceutical market, the Trump administration's new tariffs and pricing deal with the United Kingdom, and the impact on American drug prices as well as supply chain security (30:10).

<p> Thomas J. Bollyky (Council on Foreign Relations) joins to explain the problems facing the US pharmaceutical market, the Trump administration's new tariffs and pricing deal with the United Kingdom, and the impact on American drug prices as well as supply chain security (30:10).</p>

209. Will Trump's pharmaceutical tariffs lower prices and secure supply chains?

Chad P. Bown (Peterson Institute for International Economics) hosts a podcast about the economics of international trade and policy. From trade wars to trade deals, this podcast covers trade developments with insights and economic analysis from one of the world's top trade geeks.

Share 209. Will Trump's pharmaceutical tariffs lower prices and secure supply chains?

Sign up to save your podcasts

209. Will Trump's pharmaceutical tariffs lower prices and secure supply chains?

209. Will Trump's pharmaceutical tariffs lower prices and secure supply chains?